Therapeutic Action
Pancreatic antidiabetic hormone: combination of short-acting + intermediate acting insulin
PDF page 430
Loading InternPractice…
Drug reference
Pancreatic antidiabetic hormone: combination of short-acting + intermediate acting insulin
PDF page 430
Diabetes
PDF page 430
See "Insulin: general information". Do not administer if known allergy to protamine.
PDF page 430
1000 IU vial containing a combination of 30% short-acting insulin + 70% intermediate-acting insulin in suspension (100 IU/ml with a ratio of 30:70, 10 ml), for deep SC injection (abdomen, thigh, buttock or arm), administered with a syringe calibrated in insulin units for U-100 insulin (100 IU/ml). NEVER ADMINISTER BY IV INJECTION.
PDF page 430
Child and adult: one to 2 injections daily Dosage must be individualised according to need. Adapt dose in the event of physical activity, change in diet or infection.
PDF page 430
After removing vial from the refrigerator, leave to reach room temperature. Shake the vial gently before use. Also comes in biphasic human insulin 30/70 pens and biphasic analogue insulin 30/70 (aspart) and 25/75 (lispro) pens.
PDF page 430
– Do not freeze. Unopened vial: to be kept refrigerated (2 °C to 8 °C) Opened vial: max. 4 weeks at below 25 °C and protected from light. Follow manufacturer’s instructions
PDF pages 430, 431
one to 2 injections daily
PDF page 430